We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.63B
AUM Growth
+$132M
(+8.8%)
Cap. Flow
+$5.32M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
35.83%
Holding
242
New
13
Increased
68
Reduced
122
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$5.4M |
| 2 |
T-Mobile US
TMUS
|
+$4.18M |
| 3 |
STKL
SunOpta
STKL
|
+$3.19M |
| 4 |
Unilever
UL
|
+$2.34M |
| 5 |
OTLY
Oatly Group
OTLY
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$4.11M |
| 2 |
Novartis
NVS
|
+$2.88M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$1.7M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$1.65M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.91% |
| 2 | Technology | 19.96% |
| 3 | Industrials | 13.27% |
| 4 | Communication Services | 11.51% |
| 5 | Consumer Discretionary | 10.01% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Reynders McVeigh Capital Management held 242 positions worth $1.63B, up 8.8% from $1.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Reynders McVeigh Capital Management's Q2 2021 filing shows 13 new, 68 increased, 122 reduced and 10 closed positions. Its largest new stake was Oatly Group: 4,177 shares worth $2.04M. The largest sale was Teladoc Health, an estimated $4.11M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q2 2021 buy was Oatly Group: 4,177 shares worth $2.04M.
- Reynders McVeigh Capital Management added most to Medtronic in Q2 2021, an estimated $5.4M increase.
- Reynders McVeigh Capital Management's biggest Q2 2021 reduction was Teladoc Health, cutting an estimated $4.11M.
- Reynders McVeigh Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.65M.
- Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.63B portfolio in Q2 2021.
- Reynders McVeigh Capital Management opened 13 new positions and closed 10 in Q2 2021.
- Reynders McVeigh Capital Management's portfolio value rose 8.8% quarter-over-quarter to $1.63B.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.